OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Glucagon-like peptide-1 receptor agonist and sodium-glucose cotransporter 2 inhibitor use among adults with diabetes mellitus by cardiovascular-kidney disease risk: National Health and Nutrition Examination Surveys, 2015-2020
Joshua A. Jacobs, Alexander R. Zheutlin, Catherine G. Derington, et al.
American Journal of Preventive Cardiology (2023) Vol. 17, pp. 100624-100624
Open Access | Times Cited: 3
Joshua A. Jacobs, Alexander R. Zheutlin, Catherine G. Derington, et al.
American Journal of Preventive Cardiology (2023) Vol. 17, pp. 100624-100624
Open Access | Times Cited: 3
Showing 3 citing articles:
Sodium‐glucose cotransporter‐2 inhibitor (SGLT2i) plus glucagon‐like peptide type 1 receptor combination is more effective than SGLT2i plus dipeptidyl peptidase‐4 inhibitor combination in treating obese mice metabolic dysfunction‐associated steatotic liver disease (MASLD)
Pedro H. Reis‐Barbosa, Carlos Alberto Mandarim‐de‐Lacerda
Fundamental and Clinical Pharmacology (2024) Vol. 38, Iss. 6, pp. 1059-1068
Closed Access | Times Cited: 3
Pedro H. Reis‐Barbosa, Carlos Alberto Mandarim‐de‐Lacerda
Fundamental and Clinical Pharmacology (2024) Vol. 38, Iss. 6, pp. 1059-1068
Closed Access | Times Cited: 3
Association of normal range of urinary albumin‐to‐creatinine ratio with all‐cause mortality among diabetic adults with preserved kidney function: National Health and Nutrition Examination Survey (NHANES ) 2003–2018
Xiaoxia Pang, Wenchao Dan, Lan Lin, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
Xiaoxia Pang, Wenchao Dan, Lan Lin, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
Population‐level impact of semaglutide 2.4 mg in patients with obesity or overweight and cardiovascular disease: A modelling study based on the SELECT trial
Michael G. Nanna, Quan V. Doan, Anthony N. Fabricatore, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
Michael G. Nanna, Quan V. Doan, Anthony N. Fabricatore, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
